Pillar guide

GLP-1 side effects week by week

What most people experience on Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus or Saxenda across the titration phases, peak dose, and maintenance. When the symptom is normal, and when to call your prescriber.

By the Muscle Guard research team · Published 2026-05-19 · Last reviewed 2026-06-04

A week-by-week walkthrough of what most GLP-1 users experience during titration, peak dose, and plateau. Every body is different — this is a typical pattern, not a prediction. Track yours with Muscle Guard and bring the data to your next consult.

Weeks 1-4 — starting dose

Typical starting dose for semaglutide is 0.25 mg weekly; tirzepatide is 2.5 mg weekly. Symptoms users commonly report:

Action: focus on hydration (2-3 L water daily), protein (start the day with at least 25 g), and walking (light activity helps GI symptoms).

Weeks 5-12 — first titration steps

Dose escalates: semaglutide to 0.5 then 1.0 mg; tirzepatide to 5.0 then 7.5 mg. Each escalation typically brings a fresh wave of GI symptoms for 5-10 days.

Weeks 13-24 — approaching peak dose

Dose escalates further: semaglutide to 1.7 then 2.4 mg; tirzepatide to 10 then 12.5 then 15 mg. Most users reach their peak dose somewhere in this window.

Action: this is when protein and training matter most. Aim for the upper end of the 1.2-1.6 g/kg/day range and consistent resistance training.

Months 7-12 — maintenance phase

Most users settle into a rhythm. Side effects are typically minimal at this stage. New issues that may emerge:

When to call your prescriber

For non-urgent concerns, log them in Muscle Guard and bring the Doctor PDF to your next consult. The timeline view makes the conversation much faster.

Track your side effects with Muscle Guard →

Muscle Guard is a self-tracking companion and coach. Not a medical device. Not medical advice. Always consult your healthcare provider for personal decisions.

Track this with Muscle Guard

Score your muscle preservation across protein, training, weight trend and body composition.

Subscribe to the research library

Get new research articles when they ship. One email per week. No marketing, no third parties. Unsubscribe in one tap.